Memorial Sloan Kettering Cancer Center Advancing Oncology Practice 2026

1. Overview
The Memorial Sloan Kettering Cancer Center Advancing Oncology Practice 2026 program provides a comprehensive review of the latest innovations and clinical practices in oncology. The course covers diverse topics including artificial intelligence in decision-making, advanced surgical approaches, immunotherapy, Adolescent and Young Adult (AYA) oncology, and the expanding role of Advanced Practice Providers (APPs) in clinical research and patient care.
Course Date: Wednesday, March 25, 2026, 8:00 AM – Thursday, March 26, 2026, 2:30 PM, Online
This two-day live virtual symposium is designed to provide a comprehensive update on advances in cancer treatment and management across the oncology care continuum. The program will highlight current evidence-based clinical practice and research initiatives; address health inequities and wellness in the oncology population; explore the evolving role of technology and social media in healthcare; and examine emerging trends in independent oncology practice and professional development. The overarching goal of this activity is to equip healthcare professionals with practical tools to deliver state-of-the-art, collaborative, team-based cancer care — ultimately improving patient outcomes and enhancing quality of life for individuals living with cancer.
2. Learning Objectives

Identify innovative medical and surgical cancer treatment strategies for adult and pediatric cancers.
Discuss ethical considerations seen throughout the cancer care continuum.
Describe the multi-disciplinary approach and specialized teams necessary to optimize care in the oncology population.
Formulate an optimal plan for the management of patients experiencing an oncologic emergency.
Recognize inequities in the screening, diagnosis, and management of cancer.
Identify cancer risk, assessment, prevention, and treatment in patients with a hereditary predisposition.
Explain initiatives that promote advanced practice provider practice and professional development.
Describe the current and future implications of artificial intelligence, social media, and advances in technology in the cancer care landscape.

3. Target Audience

Best for oncology advanced practice providers, nurses, and physicians who want updates on AI integration, immunotherapy, and holistic care.

4. Topics

Augmenting the Clinician- Artificial Intelligence in Oncology Decision Making

Best Practices in Prognosis and Goals-of-Care Conversations

Breast Cancer in the AYA Patient- Biology, Fertility, and Beyond

Bridging the Gap- Expanding Access to Comprehensive AYA Oncology Care

Caring for Jehovah’s Witness Patients with Malignant Hematologic Diseases

Emergencology- Managing the “Can’t Miss” Diagnoses in the Outpatient Oncology Setting

Endometrial Cancer and a Surgical Approach

Ethical Dilemmas at the End of Life

From Bedside to Bench- Expanding the APP Role in Clinical Research and Innovation

From Orientation to Autonomy- The Journey to Independent Practice

From Preservation to Parenthood- Uterine Transposition in Oncofertility Care

Gender-Affirming Oncology- Best Practices for Transgender Patient Care

Healthcare Transformation Through Academic and Community-Hospitality Partnerships

Immunotherapy Toxicities (GI-Liver) — Predict, Prevent, Protect

Inherited Risk, Informed Care- Genetics in AYA Oncology

Innovations in Breast Reconstruction for Managing the Ptotic Breast

Life After Cancer- Advanced Strategies for Long-Term Survivor Care

Likes, Lies & Longevity- Healthcare Education in the Era of Misinformation

Oncology on the Air- Using Podcasts to Educate, Engage, and Empower

Oncology Symptom Care Without Borders- Expanding Access Beyond the Main Campus

Oncology’s Moral Crossroads- Navigating Ethical Conundrums in Cancer Care

One Room, Many Voices- Leveraging Shared Medical Visits in Oncology Care

Optimizing Management of Chemotherapy-Induced Thrombocytopenia in Solid Tumors- The Role of TPO-Receptor Agonists

Patient Perspective – The Rarest Journeys- A Patient’s Perspective on the Diagnosis and Treatment of Rare Tumors in AYA Oncology

Primary Palliative Care in the Community Setting

Q&A and Panel Discussion – 01

Q&A and Panel Discussion – 02

Q&A and Panel Discussion – 03

Q&A and Panel Discussion – 04

Q&A and Panel Discussion – 05

Q&A and Panel Discussion – 06

Racial Disparities in the Use of Psychedelics

RAS Therapies in Pancreas Cancer- The New Age

Ready for the Table- The APPs Impact on Preoperative Optimization and Surgical Readiness

Recent Advancements in the Management of Gastro-Intestinal Malignancies

Robotic Surgery Training Redefined- APP-Led Wet Labs in Surgical Oncology Fellowships

Safety and Efficacy Data from Nexicart-2, the First U.S. Trial of CAR-T in R-R Light Chain (AL) Amyloidosis, Nxc-201

The Emerging Role of Immunotherapy in dMMR Colorectal Cancer

The Smart OR- Artificial Intelligence in Surgical Oncology

Transplant-Associated Thrombotic Microangiopathy (TA-TMA)

Triage and Transfer in the SCC

Voices that Change Policy- APP Political Advocacy in Action – The Future of APP Practice in a Changing Legislative Landscape